Impaired learning and memory performance is often found in aging as an early sign of dementia. It is associated with neuronal loss and reduced functioning of cholinergic networks. Here we present evidence that the neurokinin3 receptors (NK3-R) and their influence on acetylcholine (ACh) release may represent a crucial mechanism that underlies age-related deficits in learning and memory. Repeated pharmacological stimulation of NK3-R in aged rats was found to improve learning in the water maze and in object-place recognition. This treatment also enhanced in vivo acetylcholinergic activity in the frontal cortex, hippocampus, and amygdala but reduced NK3-R mRNA expression in the hippocampus. Furthermore, NK3-R agonism incurred a significantly higher increase in ACh levels in aged animals that showed superior learning than in those that were most deficient in learning. Our findings suggest that the induced activation of ACh, rather than basal ACh activity, is associated with superior learning in the aged. To test whether natural variation in NK3-R function also determines learning and memory performance in aged humans, we investigated 209 elderly patients with cognitive impairments. We found that of the 15 analyzed single single-nucleotide ploymorphism (SNPs) of the NK3-R-coding gene, TACR3, the rs2765 SNP predicted the degree of impairment of learning and memory in these patients. This relationship could be partially explained by a reduced right hippocampus volume in a subsample of 111 tested dementia patients. These data indicate the NK3-R as an important target to predict and improve learning and memory performance in the aged organism.
Impaired learning and memory performance is often found in aging as an early sign of dementia. It is associated with neuronal loss and reduced functioning of cholinergic networks. Here we present evidence that the neurokinin3 receptors (NK3-R) and their influence on acetylcholine (ACh) release may represent a crucial mechanism that underlies age-related deficits in learning and memory. Repeated pharmacological stimulation of NK3-R in aged rats was found to improve learning in the water maze and in object-place recognition. This treatment also enhanced in vivo acetylcholinergic activity in the frontal cortex, hippocampus, and amygdala but reduced NK3-R mRNA expression in the hippocampus. Furthermore, NK3-R agonism incurred a significantly higher increase in ACh levels in aged animals that showed superior learning than in those that were most deficient in learning. Our findings suggest that the induced activation of ACh, rather than basal ACh activity, is associated with superior learning in the aged. To test whether natural variation in NK3-R function also determines learning and memory performance in aged humans, we investigated 209 elderly patients with cognitive impairments. We found that of the 15 analyzed single single-nucleotide ploymorphism (SNPs) of the NK3-R-coding gene, TACR3, the rs2765 SNP predicted the degree of impairment of learning and memory in these patients. This relationship could be partially explained by a reduced right hippocampus volume in a subsample of 111 tested dementia patients. These data indicate the NK3-R as an important target to predict and improve learning and memory performance in the aged organism.
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H umans exhibit a decline in cognitive capacity with age, which may progressively lead to dementia (1) . Age-dependent morphological and physiological changes within the cholinergic system of the brain have been described as a major mechanism underlying impairments of learning and memory (2, 3) . Numerous studies in aged rats have revealed that a degeneration of cholinergic neurons in the basal forebrain is associated with learning and >memory deficits (4) . Likewise, the consistent correlations found between cholinergic degeneration and cognitive impairments indicate a high correspondence between acetylcholinergic activity and the magnitude of cognitive decline (4) (5) (6) . This relationship has also been shown in patients with Alzheimer's disease (7, 8) .
The neuropeptide neurokinins (NKs) substance P, neurokinin A, neurokinin B (NK-B), neuropeptide K, neuropeptide γ, and hemokinin 1 bind to the three known NK-receptors (NK3-R) (NK1-, NK2-, and NK3-R) with different degrees of affinity, whereby NK-B is the preferred ligand to NK3-R (9) . NK3-Rs are widespread in the brain, including areas that are implicated in processes governing learning and memory such as the hippocampus, frontal cortex (FC), and medial septum (10, 11) . There is a close interaction between NK3-R and the cholinergic system. NK3-R are localized on cholinacetyltransferase-containing neurons in the basal forebrain (12) , and the activity of the septo-hippocampal cholinergic system was found to be stimulated by NK3-R agonists in adult animals (13, 14) . An involvement of NK3-Rs in learning and memory processes has also been indicated in rats and mice (14) (15) (16) (17) .
We therefore hypothesized that NK3-R stimulation would counteract cholinergic deficits and, by this means, improve learning and memory in the aged organism and carried out a functional analysis of NK3-R agonist effects on behavior and neurotransmitter activity in aged rats. To assess a potential relevance of this mechanism for humans also, we analyzed whether singlenucleotide polymorphisms (SNPs) of the NK3-R-coding gene, TACR3, are related to learning and memory performance as well as hippocampal morphology in aged humans with cognitive deficits.
Results NK3-Receptor Agonism Improves Learning in Aged Rats. Aged rats show deficits in water-maze and object recognition learning
Significance
Cognitive decline during aging impairs life quality and may lead to dementia. It is associated with a dysfunction of the brain acetylcholinergic system. Here we demonstrate that pharmacological stimulation of neurokinin3 receptors improves learning and memory in aged rats by enhancing acetylcholinergic function in the brain. In a human association study we show that a single-nucleotide polymorphism in the neurokinin3-receptorcoding gene TACR3 can predict learning and memory in elderly patients with cognitive impairments and their hippocampus volume. These findings suggest the neurokinin3 receptor as a potential biomarker and treatment target for cognitive enhancement in the elderly.
compared with adult rats (see SI Materials and Methods, SI Results, and Fig. S1 for more details). The NK3-R agonist senktide administered posttrial significantly improved learning in an objectplace recognition task (Fig. 1A ) in aged rats (17-22 mo old) . This effect was blocked by the NK3-R antagonist SR142801 (Fig. 1B) . Paired sample t tests showed that aged animals treated with vehicle-senktide (P = 0.001) and 3 mg/kg SR142801-senktide (P = 0.004) explored the spatial displaced object longer than the spatial stationary object with no difference in total exploratory activity (P > 0.05; Table S1 ). This indicates that both groups displayed an intact object-place recognition memory. In contrast, the animals treated with vehicle-vehicle, 3 mg/kg SR142801-vehicle, 6 mg/kg SR142801-vehicle, and 6 mg/kg SR142801-senktide could not distinguish between a spatial stationary and spatial displaced object within the test trial (P > 0.05).
In the water-maze task repeated posttrial administration of the NK3-R agonist senktide also significantly improved learning in the aged rats. This effect was blocked by the NK3-R antagonist SR142801 (Fig. 1C) . The two-way repeated measure analysis of variance (ANOVA) revealed a main effect of trials (F 11,484 = 18.519, P < 0.001), group (F 5,44 = 60.598, P < 0.001), and a trial × group interaction (F 55,484 = 2.128, P < 0.001). Post hoc Dunnett tests revealed significant improvements in learning in the animals treated with vehicle-senktide (P < 0.001) and 3 mg/kg SR142801-senktide (P < 0.001) compared with those given vehicle-vehicle (see SI Materials and Methods and SI Results for more statistical details). The treatment had no effect on swim velocity (Fig. S2) . There was also no significant difference between groups in the probe trial, indicating no differences between groups to remember the location of the platform and also no significant differences between groups in the cued trial, suggesting no effects of the treatment on perception and locomotor activity.
NK3-Receptor Agonism Reduces NK3-Receptor mRNA Expression in the Hippocampus of Aged Rats. Repeated treatment with the NK3-R agonist senktide reduced NK3-R mRNA expression in the hippocampus of the aged rats (Student t test, t = 3.63, P = 0.0054). This effect was blocked by pretreatment with the NK3-R antagonist SR142801 (Fig. 2A) . The agonist alone did not influence NK3-R DNA promoter methylation in the hippocampus ( Fig. 2B ; P > 0.05).
NK3-Receptor Agonism Enhances Extracellular Acetylcholine Levels in
Aged Rats. A systemic injection of the NK3-R agonist senktide led to a lasting increase in levels of extracellular acetylcholine (ACh) in the hippocampus, the FC, and the amygdala of aged rats as assessed by in vivo microdialysis. Whereas in the FC and hippocampus both doses of SR142801 blocked the effects of senktide, in the amygdala only the highest dose of SR142801 was effective ( Fig. 2C ; for more statistical details see SI Materials and Methods and SI Results).
NK3-Receptor Agonist Effects on ACh Are Most Pronounced in
Superior Aged Learners. We next asked whether the neurochemical effects of NK3-R agonism on ACh depend on the preserved learning capacity in the aged rat and compared the effectiveness of NK3-R agonist treatment in aged superior learners vs. inferior learners. We thus screened animals for object-place recognition memory (Fig. 3A) and water-maze learning (Fig. 3B ). This procedure identified n = 12 superior and n = 8 inferior learners with identical assignment of the animals to the inferior vs. superior learner groups in both tasks. In vivo microdialysis showed that there was no difference in basal extracellular ACh levels in the FC, hippocampus, or amygdala between aged superior and inferior learners (P > 0.05, Table S2 ). The NK3-R agonist senktide increased extracellular ACh levels predominantly in the superior learners in all three brain areas ( Fig. 3C ; for more statistical details see SI Materials and Methods and SI Results). mRNA analysis also showed no differences in NK3-R mRNA expression in the three brain areas analyzed (P > 0.05; Fig. S3 ).
TACR3 Polymorphism Predicts Learning in Elderly Patients. Of the 15 SNPs analyzed from the TACR3 gene (Fig. S4 ), rs2765 and rs11722288 (linkage disequilibrium, R 2 = 0.7) were significantly associated with the Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog) "word-list learning" task (n = 198; rs2765: Spearman's Rho = −0.251, P = 0.0004, p corr < 0.05; rs11722288: Spearman's Rho = −0.223, P = 0.0016, p corr < 0.05; Table S3 ). The subsequent Kruskal-Wallis tests showed gene dose-response effects between the genotype carriers [rs2765: n (AA) = 86, n (AG) = 83, n (GG) = 29, χ 2 = 12.6, P = 0.0018 (Fig. 4A) ; rs11722288: n (GG) = 105, n (GA) = 75, n (AA) = 18, χ 2 = 10.1, P = 0.0063]. Age, sex, and mild cognitive impairment vs. dementia status did not differ significantly among the rs2765 and the rs11722288 genotypes (P > 0.05) and thus were considered not to be major confounders. To confirm these findings, we further investigated the relationship of the two SNPs with word-list Fig. 1 . The neurokinin3-receptor agonist, senktide, improves object-place and water-maze learning in aged rats. Object-place recognition and watermaze learning of aged rats treated with vehicle + vehicle (VE +VE), 3 mg/kg SR142801+vehicle (3 mg SR + VE), 6 mg/kg SR142801 + vehicle (6 mg SR + VE), vehicle + 0.2 mg/kg senktide (VE + Senk), 3 mg/kg SR142801 + 0.2 mg/kg senktide (3 mg SR + Senk), or 6 mg/kg SR142801+0.2 mg/kg senktide (6 mg SR + Senk). (A) Object-place recognition design. The schematic picture shows possible object locations in the object-place recognition task. The animals received two trials with a 5-min duration and an intertrial interval (ITI) of 25 min. During the test trial, two objects known from the sample trial were presented, one in a novel position (A1, spatial displaced) and one in the same position (A2, spatial stationary) relative to the sample trials. (B) Objectplace recognition. The data are represented as means plus SE of objectexploration time (seconds) of spatial stationary and spatial displaced objects in the test trial ( # P < 0.01). (C) Water maze: mean escape latencies onto a hidden platform over 12 trials of water-maze acquisition of aged rats ( # P < 0.01; $ P < 0.001 vs. VE + VE).
learning of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) neuropsychology assessment. The Pearson correlation confirmed a significant association only between rs2765 and word-list learning (n = 209; r = 0.165, P = 0.0169; Fig. 4B ). Both tests showed an impaired performance when age-matched reference values were considered. As expected, the scores of both immediate recall tests correlated inversely with each other (n = 198, Rho = −0.527, P < 0.0001). The allelespecific analyses further corroborated the association between rs2765 and neuropsychological test results. Compared with the Gallele, the A-allele was related to a significantly higher ADAS-cog score (Mann-Whitney U test, U = 14,028, P = 0.0002) and a significantly lower CERAD score (Student t-test, t = −2.6, P = 0.0099).
TACR3 Polymorphism Predicts Right Hippocampal Volume in Elderly
Patients. Working memory performance is correlated with hippocampus volume in healthy volunteers (18) and psychiatric patients (19, 20) . We used structural magnetic resonance imaging in a subsample of 111 individuals and found an association of rs2765 with right hippocampal volume [genotype analysis (n (AA) = 50, n (AG) = 46, n (GG) = 15: Pearson correlation, r = 0.252, P = 0.0075, ANOVA, F 2,108 = 4.2, P = 0.0170 (Fig. 4C) ; allelic analysis (A/G): Student t test, t = −2.8, P = 0.0056]. There was no significant association with left hippocampal volume. The hierarchical linear regression analyses revealed that the rs2675 SNP explained 1.6% of the behavioral variance in the CERAD wordlist learning task, 1% of which was explained by right hippocampal volume. This suggests that about 62.5% (1%/1.6%) of the association between rs2765 and word-list learning (CERAD) can be explained by variation in the volume of the right hippocampus. Furthermore, about 22% (2.2%/10.2%) of the association between rs2765 and word-list learning (ADAS-cog) can be accounted for by right hippocampal volume. Altogether these data indicate that variance in the NK3-R-coding gene TACR3 is associated with reduced right hippocampal volume and learning performance in elderly patients with a broad range of cognitive impairments.
Discussion
We show that pharmacological stimulation of NK3-R can significantly enhance learning and memory in aged animals. These effects are most likely mediated by an increase of ACh levels in the major cholinergic projection target areas of the basal forebrain, together with a down-regulation of NK3-R in the hippocampus. We also show that cholinergic effects of NK3-R stimulation are most pronounced in those aged animals with an above-average learning capacity. In aged humans with cognitive impairments, we found that the rs2765 SNP in the NK3-R-coding gene TACR3 correlated with performance in learning and memory tests along with reduced right hippocampal volume. In animal models, diverse age-dependent impairments have been reported in learning and memory tasks, such as the Morris water maze (21, 22) and object recognition test (23, 24) . Aged rats exhibit deficits in water-maze acquisition as well as in discrimination between spatial stationary and spatial displaced objects compared with adult animals (SI Materials and Methods and SI Results). Our data show that the poor learning and memory performance of aged animals can be significantly enhanced by posttrial treatment with the NK3-R agonist senktide. The injection of senktide promoted memory for object location in the [In a previous microdialysis study with aged animals, we showed that systemic vehicle treatment alone had no effect on ACh neurotransmission in the frontal cortex, amygdala, and hippocampus (14) .] object-place recognition task and for the location of a hidden platform in the Morris water-maze test when given immediately after the sample trial and after each acquisition trial, respectively. This suggests that senktide was effective during the period after the learning trial when labile memory traces are liable to be facilitated or disrupted (25) . This effect was completely blocked by pretreatment with an NK3-R antagonist. The NK3-R antagonist itself did not affect learning and memory in either paradigm. These results suggest a use of NK3-R agonists as a chronic treatment to improve learning and memory performance in aged organisms that have already developed cognitive impairments.
We found that NK3-R agonism also enhances ACh activity in brain regions relevant to learning and memory. This effect was NK3-R specific because it was completely blocked by an NK3-R antagonist. NK3 receptors are located on cholinergic neurons (11, 12) , and the activity of the cholinergic system can be stimulated by NK3-R agonism in adult animals (14) . Although one cannot rule out that the increase in cholinergic activity is due to an indirect activation of cholinergic cells of the basal forebrain, it is possible that such an effect is the consequence of an excitatory activation of these cells by a direct action on NK3-Rs located on cell bodies of cholinergic cells of the basal forebrain. We found that a subchronic treatment with the NK3-R agonist, as it was done during the learning tests, also decreased NK3-R mRNA expression in the hippocampus. This adaptive effect seems to be directly linked to the activation of NK3-Rs because such activation was prevented by NK3-R antagonist pretreatment. Transcriptional activity is controlled by the methylation of the promoter DNA of the NK3-R-coding gene. However, we did not find evidence for a change in TACR3 promoter methylation, which suggests an alternative regulatory mechanism.
Previous findings reported the facilitation of age-associated learning deficits by the NK1-R ligand substance P (SP) (26).
Substance P was also found to increase ACh neurotransmission (27, 28 ). However, it is possible that the memory-facilitating effect of SP is not solely modulated by NK1-Rs on cholinergic neurons, but also by NK3-Rs, because SP, although with highest affinity to NK1-Rs, can also bind to NK3-Rs (9, 29). Our current finding of memory facilitation via NK3-R activation by senktide and the consequential increase of ACh release might also account for previously described memory-promoting effects of SP in aged animals (26) .
The pharmacological inhibition of the metabolizing enzyme acetylcholine esterase (AChE) was shown to enhance ACh levels and to improve learning and memory in the aged organism. However, AChE inhibitors can have profound side effects due to abundant AChE activity in the periphery and in the autonomous nervous system (30). NK3-R agonists have a low impact on AChmediated peripheral mechanisms (31) and therefore may offer a way to improve brain ACh activity with a reduced risk for side effects. A recent study in nonhuman primates did not find adverse behavioral effects after acute or subchronic i.p. senktide treatment, but a sensitization for the arousal-enhancing effects of cocaine (32). Subchronic treatment in adult rats had neither aversive nor appetitive effects on its own and did not impair the action of other reinforcers (33). In the present study we observed neither hyperlocomotion nor other behavioral effects that had been reported after, e.g., i.c.v. application in gerbils (34).
Aged humans and animals show considerable individual differences in performance in cognitive tasks (21, 22, 26, 27) . Ageassociated differences in sensitivity to NK3-R agonism most likely reflect differences in cholinergic degeneration (35). The cholinergic projection neurons in the basal forebrain region are reported to undergo significant atrophy in the aged rodent. The degree of atrophy is highly correlated with the cognitive impairment exhibited in the Morris water-maze task (36). However, we did not see differences in basal ACh activity or NK3-R mRNA expression. We found that the NK3-R agonist was most effective in enhancing cholinergic activity in the basal forebrain projection areas in the superior learners. The aging-associated loss of cholinergic neurons can be prevented by the endogenous NK3-R agonist NK-B (37). NK-B stimulates AChE activity in the aged brain (38). Therefore, an attenuated increase in ACh level upon senktide administration in the inferior learners may have at least partially resulted from additional AChE activation. Overall, the present data suggest that superior learning in aged animals is not due to higher basal ACh activity but rather due to its enhanced sensitivity for activation. As such, NK3-R agonists may also serve to prevent aging-associated decline in cholinergic function. However, although adult rats and nonhuman primates appear to tolerate NK3-R agonists well after subchronic treatment (32, 33), little is known about tolerance in the aged organism. Recent animal studies suggest that the use of NK3-R agonists may be limited in Parkinsons's disease (39). Although natural genetic variance can predict learning and memory performance in adults (18) , little is known about performance in the aged organism. In the present study, we investigated the genetic association of 15 SNPs in the human NK3-R-coding gene TACR3 with performance in tests of verbal learning. In a human sample of 209 patients who all exhibited cognitive impairments, we found that the r2765 SNP in the TACR3 gene predicted the degree of learning and memory impairment in two neuropsychological tests of word-list learning. Mutations in the human TACR3 gene have been shown to play an important role in puberty development and are associated with hypogonadotrophic hypogonadism (40). An association with cognitive performance has also been suggested by animal studies using NK3-R knockout mice (15) . The TACR3 polymorphism was related to encoding of new information rather than to retrieval of previously consolidated information. However, one limitation of this study is that no retrieval from long-term memory could be tested. In that, the latter possibility cannot be ruled out.
We also discovered a significant association of rs2765 with right hippocampal volume. Parts of the association of rs2765 with learning and memory performance were thereby explained by the volume of the right hippocampus. An association of word-list learning with hippocampus volume was reported previously in multiple sclerosis patients (19) . Also, patients with Alzheimer's disease show a pronounced volume loss of the hippocampus and associated areas compared with patients with mild cognitive impairments (20) . However, from our data we cannot rule out an association of TACR3 polymorphisms with learning and memory in healthy aged subjects. Altogether, current data may suggest that the rs2765 polymorphism of the TACR3 gene may provide some protection from a decline in hippocampal volume and associated loss of verbal learning capacity when dementia develops at old age.
In summary, our combined approach provides evidence for the NK3-R as a target to predict and improve learning and memory performance in aged humans and rodents. Our study identifies cholinergic mechanisms as the most likely mechanisms of action, with aged superior learners benefiting in their ACh stimulation the most from NK3-R agonism. Approaches to the use of natural genetic variance as a predictor for aging-related changes in brain morphology and for the decline of learning and memory performance may support the diagnosis of dementia, and NK3-R agonism with suitable substances may provide a principle to treat learning and memory impairments in the aged.
Materials and Methods
For a detailed methodological description, see SI Materials and Methods.
Subjects and Drugs. Eighty-two aged male Wistar rats (weight 350-750 g), 17-21 mo of age, were used for the behavioral tests and 30 animals for the in vivo microdialysis experiment. Experiments were carried out during the animals' active period. The studies were performed in accordance with the German Animal Protection Law which was approved by the Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen.
The NK3-R agonist senktide ([succinyl-Asp 6 -Me-Phe 8 ]SP [6] [7] [8] [9] [10] [11] ; Bachem) and
Effects of NK3-R Agonism on Learning and Memory, NK3-R mRNA Expression, and Promoter Methylation. For behavioral testing, 50 aged Wistar rats were randomly assigned to one of the following groups: vehicle + vehicle (n = 8), vehicle + senktide (n = 9), 3 mg/kg SR142801 + vehicle (n = 8), 6 mg/kg SR142801 + vehicle (n = 8), 3 mg/kg SR142801 + senktide (n = 9), or 6 mg/kg SR142801 + senktide (n = 8). The animals were tested in the object-place recognition and the Morris water-maze tasks (Fig. 1A) . The treatment was given after the sample trial in the case of the object-place recognition test and shortly after each acquisition trial for the Morris water-maze task. Treatment consisted of systemic administration of SR142801 (3 mg or 6 mg/kg) or its vehicle (i.p.) followed 1 min later by an injection of senktide (0.2 mg/kg) or its vehicle (s.c.). Intact object-place recognition memory was defined as increased exploration time of the spatial displaced compared with the spatial stationary object (41, 42). For the water-maze test, the acquisition phase was followed by a probe trial without a platform. Twenty-four hours later, the rats were tested in one trial in the cued platform version (43). Two weeks after the last maze test, the animals were killed and the hippocampus was dissected out. For NK3-R mRNA expression, the total RNA was extracted using a modified Qiagen protocol as described previously (44). Analysis of NK3-R promoter DNA methylation was performed via a methylation-sensitive digestion assay followed by real-time PCR as previously described (45) (for details, see SI Materials and Methods).
Effects of NK3-R Agonism on Basal Forebrain Cholinergic Activity. For the in vivo microdialysis, experimentally naive aged Wistar rats were randomly assigned to one of the following groups: vehicle + senktide (n = 5), 3 mg/kg SR142801 + vehicle (n = 5), 6 mg/kg SR142801 + vehicle (n = 6), 3 mg/kg SR142801 + senktide (n = 5) or 6 mg/kg SR142801 + senktide (n = 6). Samples were collected from the FC, amygdala, and hippocampus and analyzed for their content of ACh using high-performance liquid chromatography with electrochemical detection (HPLC-EC) as described in previous studies (14, 28) .
Effects of NK3-R Agonism on Cholinergic Activity in Superior and Inferior Aged Learners. We tested 20 naive rats for their learning and memory performance in the object-place recognition and Morris water maze, but without any treatment. The rats were then divided into two subgroups, superior (n = 12) and inferior (n = 8) learners, on the basis of their performance in the object-place recognition test and water-maze escape task. The criterion for superior and inferior performance in the water-maze task was specified a priori and was based on the animal's performance in our previous water-maze studies (14, 16). Next, the 
NK3-R mRNA Expression in Superior and Inferior Aged Learners. We measured NK3-R mRNA expression in the brain of superior and inferior learners. A new group of 12 aged animals was tested for object recognition learning (46). According to their performance, we identified six superior and six inferior learners. The day after behavioral testing, these animals were killed, and NK3-R mRNA expression was investigated in the FC, the hippocampus, and the adjacent perirhinal cortex.
Genetic Association Analysis in Patients with Cognitive Impairments. Performance in verbal learning was measured by the item word-list learning of two neuropsychological tests (aadas1, scrd7) in a sample of 209 elderly patients (50-90 y old, n = 91 males, n = 118 females), diagnosed with mild cognitive impairment or dementia (n = 59 mild cognitive impairment, n = 150 dementia) (47, 48). SNPs of the NK3-R coding gene TACR3 were genotyped using the Illumina Omni-1M-Quad array. In 111 of those participants, hippocampus volume was determined from high-resolution structural magnetic resonance images using the FMRIB' 
Object-Place
Recognition. An open-field arena (60 × 60 × 30 cm) with gray walls and open roof was used for the object-place recognition task. The arena was located in a sound-attenuating room with masking noise and four LED lights that provided a light density of 7 lx at the center of the arena. For habituation to the open field, rats were placed in the center of the arena and allowed to explore for 10 min. One day after habituation, the object-place recognition memory task, which relies on spontaneous exploration of an object, was carried out. The task consisted of a sample trial and a test trial, both of 5 min in duration and an intertrial interval of 24 h. Following the sample trial, SR142801 (3 mg or 6 mg/kg) or its vehicle was injected i.p. One minute after the first injection the animals received a second injection of either senktide (0.2 mg/kg) or its vehicle. In the sample trial two identical objects, which were allowed to be explored by the animal, were present in the open field, and in the test trial one of these objects was placed in the same position that it had been in previously (spatial stationary) and the other was placed in a novel position (spatial displaced). The times spent exploring the objects were scored, whereby object exploration was defined as physical contact with the object with vibrissae, nose, or forepaws. After each trial, the objects and the open-field arena were cleaned with 70% ethanol to remove odor cues.
Water Maze. A circular black pool (diameter, 180 cm; height, 40 cm) filled with 30 cm of water (20 ± 1°C) was used for watermaze testing. The maze was divided into four virtual quadrants. In the center of one of these quadrants, 1.5 cm below the water surface, a black circular escape platform (18 cm in diameter) was located. Diffuse illumination by six LED lights around the pool provided a light intensity of 4 lx above the water surface. At the beginning of each trial the animal was placed in the pool, facing the wall at defined starting points (north, south, east, and west) along the wall of the water maze. The order of the start positions was randomized. One habituation trial of 90 s duration was run without a platform to provide an estimate of swimming ability and motor control. Afterward the water-maze acquisition was conducted by training the rats in the hidden platform placelearning task with one trial per day for 12 consecutive days. An acquisition trial was terminated when the rat escaped onto the platform or 90 s had elapsed. In the latter case the animals were guided and placed on the platform by the experimenter. In both cases, once the animal stepped onto the platform, it was allowed to stay there for 30 s. For each rat, the submerged platform in the center of one quadrant of the water maze was maintained in a constant position throughout the acquisition trials. Shortly after each acquisition trial the injection of SR142801 (3 mg or 6 mg/kg) or its vehicle was administered i.p. One minute after the first injection the animals received another injection of either senktide (0.2 mg/kg) or its vehicle. After the acquisition phase a probe trial without a platform was conducted to examine retrieval of the previously learned platform position (it lasted maximally 90 s). In the following day, they were submitted for one trial to the cued platform with the aim of testing general sensory-motor performance (2). The cued platform was a cylinder made of steel (diameter, 2 cm; height, 25 cm) painted with black and white stripes. A trial was terminated when the animal escaped onto the platform or 90 s had elapsed, after which the rat was guided to the platform. Once at the platform, the animal was allowed to stay for 30 s. The time to reach the platform was monitored by a tracking software (Ethovision). The time required to locate the platform over trials is taken as an index of learning. In the probe trial, the time spent within the previously rewarded platform quadrant was analyzed. In the cued version, the time to reach the platform was ascertained. In Vivo Microdialysis Procedure. The preparation of the microdialysis probes has been described previously by Boix et al. (4, 5) . The microdialysis experiment was conducted during urethane anesthesia (1.25 g/kg, Sigma Aldrich). The probes had an active membrane length of 2.0 mm for frontal cortex and amygdala and 4.0 mm for the hippocampus. To allow fluid supply without physical contact with the animal, a catheter was placed into the i.p. cavity. The animal was placed in an acrylic box (45 × 25 × 22 cm), and the body temperature was monitored and held stable at 36.5 ± 0.5°C by a temperature controller (CMA/150) and a heating pad. The microdialysis probes were connected to a microinfusion pump (CMA/100) and were perfused with Ringer's solution containing neostigmine (10 μmol) with a flow rate of 2 μL/min. Samples were collected in cups containing 10 μL of nitric acid solution containing the internal standard ethylhomocholine. After a 2-h stabilization period, six baseline samples, each corresponding to a time window of 10 min, were collected. After the treatment, another 10 samples (10 min per sample) were collected.
HPLC Analysis. After collection, the microdialysis samples were analyzed for the concentration of acetylcholine (ACh) by highperformance liquid chromatography with electrochemical detection (HPLC-EC) according to standard method (6) . The analytical column (75-mm length, 2-mm inner diameter) was filled with ChromSpher 5C18 (Merck) and loaded with sodiumdodecylsulfate (Sigma-Aldrich). The enzyme reactor was filled with LiChrosorb-NH 2 (Merck), activated by glutaraldehyde (Merck), and loaded with acetylcholineesterase (Sigma-Aldrich) and cholineoxidase (Sigma-Aldrich) and was attached to the end of the analytical column for enzymatic cleavage of ACh. The enzymes were covalently bound to the stationary phase. On passage through the enzyme reactor, ACh was converted to hydrogen peroxide, which was electrochemically detected at a platinum electrode set at a potential of 0.350 mV vs. an Ag/AgCl reference electrode (Antec). The mobile phase, consisting of 1 mM tetramethylammonium chloride (Merck) and 0.18 M K 2 HPO 4 (Merck) and adjusted to pH 8.0 with KH 2 PO 4 (Merck), was delivered by a HPLC pump (Merck) at a flow rate of 0.3 μL/min (6) . The data were collected, processed, and stored with the help of computer software (Chrom Perfect, Justice Laboratory Software).
Histology. After the microdialysis experiment, the animals were deeply anesthetized with pentobarbital (Sanofi Ceva) and perfused with PBS and 10% formalin through the left heart ventricle. The brain was removed and stored in 10% formalin until histological verification. After slicing the brain with a cryostat (Leica), slices were stained with cresyl violet (Sigma-Aldrich).
The accuracy of probe placement was verified according to a brain atlas (3) . Only data from animals with correct probe placement were considered for statistical analysis.
Tissue Preparation and RT-PCR Analysis. Two weeks after the water maze test, the brains were removed, frozen with dry ice, and kept at −80°C. For neurokinin3-receptors (NK3-R) mRNA expression the hippocampus was dissected. Total RNA was extracted using a modified Qiagen protocol as described previously (7) . A phenol extraction in Qiazol (Qiagen) was followed by column purification with Rneasy Mini Kit (Qiagen), including DNase digestion according to the manufacturer's protocol. cDNA was synthesized using an iScript cDNA Synthesis Kit (Bio-Rad) following manufacturer's instructions. Quantitative RT-PCR was performed using SYBR Green I Master Mix buffer (Applied Biosystems), and reactions were run on an iCycler (Roche) using a three-step standard protocol. The annealing temperature was optimized for all primer pairs and ranged from 55 to 65°C. PCR products were visualized on standard 2% agarose gels with ethidium bromide to eliminate the possibility of having amplified genomic DNA. β-Actin was used as internal standard, and cyclethreshhold (CT) values were calculated from differences between β-actin and the target genes. Fold changes were calculated using the delta-delta-CT (DDCT) method to analyze the relative changes in gene expression as described previously (Applied Biosystems manual). All experiments were repeated at least three times, and the mean value was used for further analysis.
The following primer pairs were used: β-actin-F-GGGAAATC-GTGCGTGACATT; β-actin-R-GCGGCAGTGGCCATATC; NK3-R-5′ TGGGGTCAAACAGCACGG′3; and NK3-F-5′ GAGAGATCCCAGGAGACA′3.
Promoter Methylation Analysis. Genomic DNA was extracted from whole tissue with the QIAamp DNA Blood and Tissue Kit (QIAGEN Inc.) according to the manufacturer's instructions. Afterward, 0.5-1 mg of genomic DNA was digested overnight with a 10-fold excess of HpaII or MspI endonuclease according to the manufacturer's protocol (New England Biolabs). MspI cuts independently from methylation status at 5′-CCGG-3′ sites, whereas cutting of HpaII depends on the respective DNAmethylation status. In a 20-mL assay, altogether 40 U of each restriction enzyme was used for 16 h with initially 20 U and another 20 U additionally after 4 h to complete DNA digestion.
To measure promoter methylation of the NK3-R, quantitative PCR of the NK3-R promoter was performed using an SYBR Green I Master Mix buffer (Applied Biosystems) with the following primers: NK3-R meth-F-5′GGGGGAAGGAATATT-TTTTTC′3 and NK3-R meth-R-5′ATCTACGCTAAAAAC-GCGCT′3.
To amplify the specific promoter region covering a cytosinephosphodiester-guanine (CpG) island of ∼600 bp, PCR was performed as follows: PCR was carried out with a final volume of 25 μL, containing 1 μL of each primer, 1 μL of digested template DNA, and 12.5 μL SYBR green (Bio-Rad). The amplification was done with initial denaturing at 97°C for 10 min, followed by 50 cycles of denaturing at 95°C for 2 min, annealing for 90 s at 53°C
, and extension for 1 min at 72°C. The product was visualized with a 2% agarose gel. All experiments were repeated two times. CT measurements were transformed using the formula % = [1_ (2CT_HpaII/2CT_MspI)] × 100 to calculate the percentage of methylation change.
Criteria for Classification of Behavioral Performance as Superior or
Inferior. Twenty naive rats were tested for their learning and memory performance in the object-place recognition and Morris water maze (2, 8) . On the basis of their performance, the rats were divided into two subgroups: superior and inferior learners. Intact object-place recognition memory was defined by more exploration of the spatial displaced object in comparison with the spatial familiar object. The superior learner group (n = 12) consisted of those animals that explored the spatial displaced object longer than the spatial familiar object. According to this criterion, all other animals were classified as inferior learners (n = 8). To also classify the performance during water-maze acquisition, the time to escape onto the platform for each animal and the acquisition trial were descriptively compared separately with the mean time (+2 SEM) for the entire animal group on each acquisition trial. Thereby, for a given trial, animals that escaped onto the platform faster than the calculated mean (+2 SEM) time were assigned to the superior performance group and animals that required more time were assigned to the inferior performance. The minimum requirement for classifying an animal in the superior performance group was that it would be classified as a superior performer in at least 13 of the total 24 acquisition trials.
Genetic Association Analysis in Patients with Cognitive Impairments.
The genetic association of 15 SNPs in the human NK3-R-coding gene TACR3 with performance in verbal learning as measured by the items word-list learning of two neuropsychological tests (aadas1, scrd7) was investigated in a sample of 209 elderly patients (n = 91 males, n = 118 females) with cognitive impairments (n = 59 mild cognitive impairment, n = 150 dementia). All participants were recruited within the early diagnostic and prognostic program of the German Dementia Competence Network at each of the 13 participating sites in Germany with the diagnosis of mild cognitive impairment or dementia (9, 10) . Participants were between 50 and 90 y old (71.4 ± 0.58; mean ± SEM). The Illumina Omni-1M-Quad array was used for genotyping. This array included 32 SNPs located around the TACR3 gene [University of California, Santa Cruz RefSeq Gene chr4: 104510625-104640973 (NM_001059); extended predefined genomic region of interest: chr4:104500625-104645973]. Nine SNPs were excluded from the analyses due to a minor allele frequency (MAF) <5% (rs13113337, rs10018767, rs6533105, rs977291, rs10004171, rs10013998, rs10016918) or a significant deviation from Hardy-Weinberg equilibrium (HWE) (rs6533101, rs12641703) . Moreover, the following eight SNPs were excluded because of a
rs3733631). To analyze MAFs, HWE, and linkage disequilibrium (LD) structure, we used haploview version 4.2 (www.broad.mit.edu/mpg/hapoview/; LD plot). Altogether, 15 SNPs were tested for association with word list learning tasks of the Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog) and Consortium to Establish a Registry for Alzheimer's Disease (CERAD) battery (11) . Both test batteries include a word list paradigm with immediate recall. The scores for immediate recall indicate the mean number of errors from three word list repetitions [ADAS-cog; maximum impairment: 10; normal aged (50-99 y old): ∼5] or the sum of correctly recalled words [CERAD; maximum achieved: 30; normal aged (70-79 y old): 18.7-22.7] from the list.
Statistical Analysis. Object-place recognition. Data obtained on the exploration times were expressed as means (± SEM). Paired sample t tests (two-tailed) were conducted to analyze if each treatment group separately was able to discriminate between the objects during the test trial. Water maze. Two-way repeated measures ANOVA were conducted for statistical analysis of water-maze escape latency during acquisition with the factors "trial" and "group." Post hoc Dunnett tests were applied for between-group comparisons. When appropriate, this was followed by a one-way ANOVA and post hoc Dunnett test to analyze group differences at individual time points. For the probe trial and cued trial, one-way ANOVA with factor "group" was conducted. Post hoc Dunnett tests were used to assess between-group differences. mRNA expression and methylation. Independent t tests were calculated. In vivo microdialysis. Data were analyzed for each brain area separately. ACh concentrations were analyzed as percentage of baseline with the mean of the six baseline samples taken as 100%. A two-way ANOVA with repeated measures was calculated with the factors "time" and "group." Post hoc Dunnett tests were applied for between-group comparisons. When appropriate, this was followed by a one-way ANOVA and post hoc Dunnett tests to analyze group differences at individual time points. Association analysis. Depending on whether neuropsychological test results or hippocampal volumes were normally distributed according to the Kolmogorov-Smirnov test, we used parametric (Pearson correlation, Student t test, ANOVA) or nonparametric methods (Spearman correlation, Mann-Whitney U test, KruskalWallis test). In a first step, we calculated Spearman correlations followed by Kruskal-Wallis tests to investigate dose-dependent effects between SNPs and the aadas1 score (ADAS-cog). For replication, we then tested whether the initially identified SNPs were also related to word list learning in another neuropsychological test (scrd7, CERAD) and to hippocampal volumes. For allele-specific analyses homozygous and heterozygous carriers were counted twice. In a second step, we calculated hierarchical linear regression analyses to estimate the contribution of hippocampal volume to the relationship between the identified SNP and neuropsychological test performance. In model 1, the genetic data were entered first and hippocampal volumes were entered second. In model 2, hippocampal volumes were entered first and the genetic data second. The P values were considered significant if α ≤ 0.05. P values were corrected for multiple testing according to Bonferroni. IBM SPSS Statistic 20.0 was used for all analyses.
SI Results
Age-Dependent Impairment in Water-Maze Acquisition and ObjectPlace Recognition. To determine whether aged rats have deficits in learning and memory compared with adult rats, we tested adult (3 mo of age, n = 10) and aged (19 mo of age, n = 15) animals in the Morris water maze as well as in an object-place recognition task. We found an age-dependent deficit in object-place recognition (Fig. S1A) . A paired-samples t test showed that the adult animals explored the spatial displaced object longer than the spatial stationary object (P < 0.001), indicating intact objectplace recognition. The aged animals were impaired in the objectplace recognition task; i.e., they were not able to distinguish between a spatial stationary and spatial displaced object (P > 0.05).
For the water-maze paradigm these animals were trained in the hidden platform place-learning task on 7 consecutive days. The two-way repeated measures ANOVA revealed a main effect of days (F 6,132 = 2.191, P = 0.048) and group (F 1,22 = 15.034, P = 0.001) but no interaction (F 6,132 = 1.174, P > 0.05). The t-tests revealed significant differences between adult and aged rats during acquisition (day 4: P = 0.014; day 5: P = 0.048; day 7: P < 0.001). These results showed that the time to the hidden platform was significantly shorter in the adult compared with the aged animals, indicating an age-dependent deficit in water-maze acquisition (Fig. S1B) . Post hoc Dunnett test revealed significant decreases in the time to the platform for the groups treated with vehicle + senktide (trials 2-8: P < 0.001; trial 9: P = 0.005; trial 10: P = 0.009; trial 11: P < 0.001) and 3 mg/kg SR142801 + senktide (trials 2-7: P < 0.001; trial 8: P = 0.002; trial 11: P = 0.001) compared with the vehicle + vehicle control group. In the probe trial, the time spent within the former platform quadrant was analyzed. A one-way ANOVA revealed no significant differences between treatment groups (F 5,49 = 0.419, P > 0.05), indicating that all aged animals remembered the location of the platform at a comparable level. There were also no significant differences between treatment groups in the cued trial (one-way ANOVA, F 5,49 = 0.679, P > 0.05), which suggests that the NK3-R ligands did not influence perception and locomotor activity.
The NK3-R agonist senktide has also a significant effect on distanced moved during water-maze acquisition in the aged rats. This effect was blocked by the NK3-R antagonist SR142801 (Fig.  S2) . The two-way repeated measures ANOVA for the parameter distance moved revealed a main effect of trials (F 11,473 = 25.028, P < 0.001), group (F 5,43 = 53.812, P < 0.001), and a trial × group interaction (F 55,473 = 3.303, P < 0.001). Post hoc Dunnett tests revealed a significant difference of vehicle + senktide (P < 0.001) and 3 mg/kg SR142801 + senktide (P < 0.001) compared with vehicle + vehicle-treated animals. One-way ANOVA showed significant differences in distance moved on acquisition trial 2 (F 5,49 = 26.231, P < 0.001), trial 3 (F 5,49 = 20.051, P < 0.001), trial 4 (F 5,49 = 28.103, P < 0.001), trial 5 (F 5,49 = 20.669, P < 0.001), trial 6 (F 5,49 = 25.539, P < 0.001), trial 7 (F 5,49 = 18.193, P < 0.001), trial 8 (F 5,49 = 8.153, P < 0.001), trial 9 (F 5,49 = 7.656, P < 0.001), trial 10 (F 5,49 = 5.978, P < 0.001), trial 11 (F 5,49 = 9.560, P < 0.001), and trial 12 (F 5,49 = 3.298, P = 0.013). Post hoc Dunnett test revealed significant decreases in distance moved in the groups treated with vehicle + senktide (trials 2-8: P < 0.001; trial 9: P = 0.008; trial 10: P = 0.003; trial 11: P < 0.001; trial 12: P = 0.048) and 3 mg/kg SR142801 + senktide (trials 2-7: P < 0.001; trial 8: P = 0.003; trial 11: P < 0.001) compared with the vehicle + vehicle controls.
Velocity was not affected by the treatment. A two-way repeated measures ANOVA for the parameter velocity indicated a main effect of trials (F 11,429 = 1.898, P = 0.038) and a trial × group interaction (F 55,429 = 1.839, P < 0.001), but no main effect of group (F 5,39 = 0.666, P > 0.05).
NK3-Receptor Agonism Enhances Extracellular ACh Levels in Aged
Rats. After histological screening for correct placement of the microdialysis probes, all 30 animals were considered for statistical analysis. The mean ± SEM basal levels of ACh in dialysates were the following: frontal cortex, 1.546 ± 0.459 pmol/15 μL; amygdala, 1.893 ± 0.655 pmol/15 μL; and hippocampus, 2.346 ± 0.725 pmol/15 μL. There was no baseline difference in ACh levels between treatment groups (P > 0.05). Frontal cortex. A two-way repeated measures ANOVA revealed a significant main effect of time (F 15,315 = 13.283, P < 0.001), group (F 4,21 = 10.920, P < 0.001), and a time × group interaction (F 60,315 = 5.631, P < 0.001) in ACh neurotransmission. Post hoc Dunnett tests revealed significant differences between groups treated with 3 mg/kg SR142801 + vehicle (P < 0.001), 6 mg/kg SR142801 + vehicle (P < 0.001), 3 mg/kg SR142801 + senktide (P = 0.002), and 6 mg/kg SR142801 + senktide (P = 0.001) and the group treated with vehicle + senktide (Fig. 2C) . Amygdala. A two-way repeated measures ANOVA showed a significant main effect of time (F 15,315 = 12.727, P < 0.001), group (F 4,21 = 7.630, P = 0.001), and a time × group interaction (F 60,315 = 3.009, P < 0.001) in ACh levels. Post hoc Dunnett tests displayed significant differences between the 3 mg/kg SR142801 + vehicle (P < 0.001), 6 mg/kg SR142801 + vehicle (P = 0.006), and 6 mg/kg SR142801 + senktide (P = 0.001) and the vehicle + senktidetreated rats, whereas 3 mg/kg SR142801 + senktide (P > 0.05)-treated rats did not differ significantly from the vehicle + senktide group (Fig. 2C) . Hippocampus. A two-way repeated measures ANOVA revealed a main effect of time (F 15,300 = 18.046, P < 0.001), group (F 4,20 = 28.234, P < 0.001), and a time × group interaction (F 60,300 = 5.499, P < 0.001) in ACh levels. Post hoc Dunnett tests revealed significant differences between the groups treated with 3 mg/kg SR142801 + vehicle (P < 0.001), 6 mg/kg SR142801 + vehicle (P < 0.001), 3 mg/kg SR142801 + senktide (P < 0.001), and 6 mg/kg SR142801 + senktide (P < 0.001) compared with the vehicle + senktide group (Fig. 2C ).
NK3-Receptor Agonist Effects Are Most Pronounced in Superior Aged
Learners. Object-place recognition. During the test trial the superior learners explored the spatial displaced object longer than the spatial familiar object (P < 0.001), indicating that this group had an intact object-place recognition memory. The inferior rats explored the object in the spatial familiar location more than the spatial displaced object (P = 0.03). This indicates that these animals could not register the spatial location of objects during the sample trial or could not maintain it in storage. This procedure identified n = 12 superior and n = 8 inferior learners (Fig. 3A) . Morris water maze. For each of the 6 acquisition days and four daily trials, the time to the platform was averaged for the superior and inferior learner groups (Fig. 3B) . The two-way repeated measures ANOVA revealed a main effect of days (F 5,90 = 12.528, P < 0.001) and group (F 1,18 = 33.208, P < 0.001), but no interaction (F 5,90 = 2.207, P > 0.05). The t-tests revealed a significant difference between the superior and inferior groups during acquisition (days 3-5: P ≤ 0.001; day 6: P = 0.029). These results showed that the time to the hidden platform was significantly shorter in the superior learners (P < 0.001) over the course of the 6 acquisition days indicative of superior learning, whereas the inferior learners showed deficits in learning (P > 0.05). There were no differences between the groups in the probe trials and the cued trials (P > 0.05).
After histology, 16 animals were considered for statistical analysis of ACh levels [sample sizes; frontal cortex (FC): superior n = 9, inferior n = 7; amygdala: superior n = 7, inferior n = 7; hippocampus: superior n = 9, inferior n = 7). The NK3-R agonist senktide increased extracellular levels predominantly in the superior learners in all three brain areas (Fig. 3C) . For the FC, a two-way repeated measures ANOVA revealed a main effect of time (F 15,210 = 6.864, P < 0.001) and a time × group interaction (F 15,210 = 3.231, P < 0.001), but no main effect of group (F 1,14 = 4.202, P > 0.05) in ACh levels. The t-tests showed that treatment with 0.2 mg/kg senktide significantly increased ACh release in the superior learners at 60 min (P = 0.031) and at 100 min (P = 0.026) after injection compared with the inferior learners. For the amygdala, a two-way repeated measures ANOVA revealed a main effect of time (F 15,180 = 12.024, P < 0.001), group (F 1,12 = 23.850, P < 0.001), and a time × group interaction (F 15,180 = 6.960, P < 0.001) in ACh levels. The t-tests showed that the superior learners had an increase in ACh release (20 min: P = 0.006; 30 min: P = 0.011; 40 min: P = 0.002; 50 min: P = 0.002; 60 min: P = 0.013; 70 min: P = 0.002; 80 min: P < 0.001; 90 min: P = 0.001; and 100 min: P = 0.005) in comparison with the inferior learners after senktide application. For the hippocampus, a two-way repeated measures ANOVA revealed a main effect of time (F 15,210 = 28.115, P < 0.001), group (F 1,14 = 12.345, P = 0.003), and a time × group interaction (F 15,210 = 7.488, P < 0.001) in ACh levels. The t-tests showed that the treatment with senktide significantly increased ACh release 20 min (P = 0.003), 30 min (P = 0.003), 40 min (P = 0.004), 50 min (P = 0.004), 60 min (P = 0.018), 70 min (P = 0.008), 80 min (P = 0.014), 90 min (P = 0.005), and 100 min (P = 0.007) after injection in the superior compared with the inferior learners. S4 . Structure of the TACR3 gene according to University of California, Santa Cruz genome browser (https://genome.ucsc.edu; NM_001059). Within the predefined genomic region (chr4:104500625-104645973), 32 SNPs were genotyped using the Illumina Omni-1M-Quad array. Nine SNPs were excluded due to a MAF < 5% or a deviation from HWE. The figure illustrates the remaining 23 SNPs. Another 8 SNPs were excluded due to LD (R 2 ≥ 0.8). The remaining 15 SNPs were used in the statistical analyses. Haplotype blocks are defined according to confidence intervals. Numbers in squares denote pairwise R 2 between single markers. Gray scheme encodes LD between markers using R 2 confidence intervals (uninformative, light-gray and dark-gray; strong evidence for LD, black; strong evidence for recombination, white). The object exploration time of vehicle + vehicle (VE + VE), 3 mg/kg SR142801 + vehicle (3 mg SR + VE), 6 mg/kg SR142801 + vehicle (6 mg SR + VE), vehicle + 0.2 mg/kg senktide (VE + Senk), 3 mg/kg SR142801 + 0.2 mg/ kg senktide (3 mg SR + Senk), or 6 mg/kg SR142801 + 0.2 mg/kg senktide (6 mg SR + Senk) treated aged rats is presented as mean ± SEM during the test trial. Please note that, although neither senktide nor SR142801 had a significant effect on locomotor activity on their own, the combination of 6 mg SR + Senk showed a tendency for reduced exploratory activity. However, this effect did not reach statistical significance (F 5,49 = 0.56, P = 0.73). Although this may not explain the memory-enhancing effects of senktide, it may nevertheless contribute to its canceling out. 
